Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
5
Mins
24 Jul 2025
MRD in Clinical and Regulatory Decisions
THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease (MRD)…
4
Mins
24 Jul 2025
Vitamin K-Dependent Bleeding Linked to Topiramate
Topiramate is a well-known medication used for migraine and epilepsy. Bleeding is a rare and less documented side-effect of this treatment…
5
Mins
24 Jul 2025
Evolving Endpoint Strategies
SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex conditions…
23 Jul 2025
Hema Now: Episode 22: The State of Sickle Cell
Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.
22 Jul 2025
ICML 2025: Combining Radiation and Bispecific Antibodies in Blood Cancer
A new study presented at the 2025 International Conference on Malignant Lymphoma (ICML) has shown that radiation therapy can be safely integrated with bispecific antibody treatment in patients with relapsed or refractory blood cancers…
22 Jul 2025
ICML 2025: Blood Test Shows Promise for Tracking Lymphoma Relapse Risk
Real-world data presented at the 2025 International Conference on Malignant Lymphoma (ICML) has provided new insights into the use of clonoSEQ, a circulating tumour DNA (ctDNA) assay…
22 Jul 2025
Supporting Treatment Decision-Making for Lenalidomide-Refractory Multiple Myeloma Patients Post-DRd in Italy: A Multi-Criteria Decision Framework.
In these short video series, Elena Zamagni, coauthor of the EMN Research Italy publication, shares key insights on managing…
21 Jul 2025
ICML 2025: Regional and Socioeconomic Disparities in CNS Lymphoma Outcomes
A large-scale national study of primary central nervous system lymphoma (PCNSL) in England has revealed stark differences in incidence and survival based on geography, age, and deprivation…
Loading posts...
« Previous
1
…
12
13
14
15
16
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View